These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7638634)

  • 21. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
    Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
    Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myeloid leukemia with osteolytic bone involvement.
    Prabhash K; Loknath D; Babu KG; Hasib AG; Biswas S; Bapsy PP
    J Assoc Physicians India; 2003 Jul; 51():740-1. PubMed ID: 14621059
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular mechanisms of transformation by the BCR-ABL oncogene.
    Sattler M; Griffin JD
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):4-10. PubMed ID: 12783368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic myelogenous leukemia as gene activation model in oncology minireview.
    Zámecníková A
    Neoplasma; 2000; 47(5):269-73. PubMed ID: 11130241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous presence of major secondary chromosomal abnormalities in blast crisis of chronic myeloid leukemia.
    Lu CM; Wang E; Lawrence HJ
    Cancer Genet Cytogenet; 2007 Jan; 172(2):174-5. PubMed ID: 17213030
    [No Abstract]   [Full Text] [Related]  

  • 26. [Basophilic blast crisis in chronic myeloid leukemia].
    García Fernández JR; montalbán MA; Martín ML; Ortiz MC; Martínez MA; García Marcilla A
    Sangre (Barc); 1998 Oct; 43(5):430-2. PubMed ID: 9868337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase: obviously activated in the accelerated phase of chronic myeloid leukemia.
    Li G; Song YH; Qian LS; Ma XT; Wu KF
    Haematologica; 2000 Nov; 85(11):1222-4. PubMed ID: 11064478
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical manifestations of chronic granulocytic leukemia.
    Spiers AS
    Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of RbAp46 gene in patients with acute leukemia or chronic myelogenous leukemia in blast crisis.
    Hu SY; Chen ZX; Gu WY; Cen JN; Zhao Y
    Chin Med J (Engl); 2005 Aug; 118(15):1295-8. PubMed ID: 16117885
    [No Abstract]   [Full Text] [Related]  

  • 31. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
    Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV
    Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
    Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
    Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comment on Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.
    Lazarevic VLj
    Leuk Res; 2010 Sep; 34(9):1253. PubMed ID: 20378169
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypothesis: additional cytogenetic abnormalities and progression to acute phase in chronic myelogenous leukemia.
    Aurer I; Canaani E; Gale RP
    Leukemia; 1991 Nov; 5(11):1012-3. PubMed ID: 1961031
    [No Abstract]   [Full Text] [Related]  

  • 35. A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes.
    Preisler HD
    Cancer Genet Cytogenet; 1988 May; 32(1):133-42. PubMed ID: 3162703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The inducing effect of retinoic acid and harringtonine on differentiation of human leukemic cells in primary culture].
    Ji H
    Zhonghua Yi Xue Za Zhi; 1988 Sep; 68(9):509-12, 36. PubMed ID: 3228752
    [No Abstract]   [Full Text] [Related]  

  • 37. [The diagnosis of a hemorrhagic syndrome in chronic myeloleukemia].
    Sakhibov IaD; Sagdieva NSh; Shneĭvaĭs VB; Kalmykova IB
    Ter Arkh; 1995; 67(7):26-30. PubMed ID: 7482299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetics and oncogenes.
    Williams DL
    Curr Opin Oncol; 1990 Feb; 2(1):26-33. PubMed ID: 2095229
    [No Abstract]   [Full Text] [Related]  

  • 39. The distinctive micromegakaryocytes of transformed chronic myeloid leukemia.
    Fordham NJ; Stern S; Swansbury J; Bain BJ
    Am J Hematol; 2016 Mar; 91(3):350. PubMed ID: 26749024
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of dipyridamole, theophyllamine and verapamil on spontaneous in vitro proliferation of myelogenous leukaemia cells.
    Bruserud O
    Acta Oncol; 1992; 31(1):53-8. PubMed ID: 1586506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.